Definitive chemoradiotherapy with simultaneous integrated boost of radiotherapy dose for T4 esophageal cancer-will it stand for a standard treatment?

Satoru Matsuda; Shuhei Mayanagi; Tomoyuki Irino; Hirofumi Kawakubo; Yuko Kitagawa

doi:10.21037/jtd.2019.12.59

Definitive chemoradiotherapy with simultaneous integrated boost of radiotherapy dose for T4 esophageal cancer-will it stand for a standard treatment?

Satoru Matsuda, Shuhei Mayanagi, Tomoyuki Irino, Hirofumi Kawakubo, Yuko Kitagawa

Research output: Contribution to journal › Editorial › peer-review

Original language	English
Pages (from-to)	5682-5684
Number of pages	3
Journal	Journal of Thoracic Disease
Volume	11
Issue number	12
DOIs	https://doi.org/10.21037/jtd.2019.12.59
Publication status	Published - 2019 Dec 1

ASJC Scopus subject areas

Pulmonary and Respiratory Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.21037/jtd.2019.12.59

Cite this

@article{b0d2044c03884f5580ba7d4009c53d53,

title = "Definitive chemoradiotherapy with simultaneous integrated boost of radiotherapy dose for T4 esophageal cancer-will it stand for a standard treatment?",

author = "Satoru Matsuda and Shuhei Mayanagi and Tomoyuki Irino and Hirofumi Kawakubo and Yuko Kitagawa",

year = "2019",

month = dec,

day = "1",

doi = "10.21037/jtd.2019.12.59",

language = "English",

volume = "11",

pages = "5682--5684",

journal = "Journal of Thoracic Disease",

issn = "2072-1439",